ResMed outlines FY 2027 $5.75B-$5.85B revenue outlook while targeting $1.85B+ shareholder returns
Seeking Alpha · 市场快讯 · October 29, 2026 at 8:59 PM ET
Read the full report at the original publisher.
Seeking Alpha · 市场快讯 · October 29, 2026 at 8:59 PM ET
Read the full report at the original publisher.